TABLE 1.
Primer namea | Restriction site | Sequenceb (5′–3′) | Nucleotide positionc |
---|---|---|---|
Primers for construction of gH CD mutants | |||
DH-3 | EcoRI | AGA ATT CAA AGT TTG CCG TGC CCG TC | 60748–60766 |
gH_ECD R | XhoI | CACACTCGAGCTACGGGGACACGGGCGC | 62693–62707 (r) |
gH Δ668-686 | XhoI | CACACTCGAGCTAGAATAGGGCGTACAGGATCCC | 62750–62770 (r) |
gH Δ670-686 | XhoI | CACACTCGAGCTACATCTTGAATAGGGC | 62762–62776 (r) |
gH Δ678-686 | XhoI | CACACTCGAGCTAGCCCTCGGAGGA | 62780–62809 (r) |
gH Δ682-686 | XhoI | CACACTCGAGTAACCGAGAATAGCC | 62812–62798 (r) |
Primers for construction of gH Y678A | |||
gH Y679A F | CCTCCGAGGGCGCTTCTCGGTTAATAAACG | 62790–62819 | |
gH Y679A R | CGTTTATTAACCGAGAAGCGCCCTCGGAGG | 62790-62819 (r) | |
Primer for construction of gH-gpi | |||
gH Ka HindIII F | HindIII | CACAAGCTTAAAGTTTGCCGTGCCCGTC | 60748–60766 |
gH ECD EcoRV R | EcoRV | CACAGATATCCGGGGACACGGGCGCGAGCCG | 62687–62707 (r) |
Primers for construction of gH chimeras | |||
P CD H TMD F | TGGTTATGATTACCGCCGCCCTGGCTGGCATCCTA/AAGATGCTCTGCAGC | H, 43828–43862; P, 62771–62785 | |
P ECD H TMD R | ATCATAACCACGCCCAGCGCAGAGGCGGCCAGAA/AGGCCGGGGACACGGG | H, 43853–43886; P, 62696–62711 (r) | |
P ECD H TMD CD F | TCGCGCCCGTGTCCCCGGCC/TTTCTGGCCGCCTCTGCG | H, 43870–43887; P, 62691–62711 | |
P ECD H TMD CD R | GCCAGCCAGGGCGGCGGTAATCATAACCACGCCCAGCGCAGAGGCGGCCAGAA/AGGCCGGGGACACGGGCGCGAGCC | H, 43834–42886; P, 62688–62711 (r) | |
H TMD P CD | GCCGCCTCTGCGCTGGGCGTGGTTATGATTACCGCCGCCCTGGCTGGCATCCTA/ATGCTCTGCAGCTTCTCCTCCGAGG | H, 43828–43881; P, 62774–62798 | |
gH Ka ECD gD TMD R | CGTGCCGACGATCACCGA/CGGGGACACGGGCGCGAGC | gD Ka, 122199–122215; gH Ka, 62689–62707 (r) | |
gH Ka ECD gD TMD F | GCTCGCGCCCGTGTCCCCG/TCGGTGATCGTCGGCACG | gH Ka, 62689–62707; gD Ka, 122198–122215 | |
gD TM gH CD F | ACCGCGATGGGCGCGCTCCTGGTGGGCGTGTGCGTCTACATCTTCTTC/AAGATGCTCTGCAGCTTC | gH Ka, 62771–62788; gD Ka, 122219–122266 | |
gD TM gH CD R | AGGAGCGCGCCCATCGCGGTGCCCGTGCCGACGATCACCGAC/GGGGACACGGGCGCGAG | gH Ka, 62707–62690; gD Ka, 122198–122238 (r) | |
HHV1gH-R | XhoI | CACACTCGAG TTA TTCGCGTCTCC | 43783–43796 (r) |
US6-rev | EcoRI | CACAGAATTCC ATC GACGCCGGTACTGC | 121353–122370 (r) |
DHrev1 | XbaI | CATCTAGACACGCGCACGCAGAGAGT | 62856–62874 (r) |
Primer for sequencing | |||
T7 | TAATACGACTCACTATAGGG | pcDNA3 | |
SP6 | CTCTAGCATTTAGGTGACACTATAG | pcDNA3 (r) | |
gH-WH3 | TGCACGAGAGCGACGACTACC | 61479–61499 | |
gH-WH6 | GGACATCGCCAACCCGCTCG | 62356–62375 |
Designations and components of the OE primers specify the virus. P, PrV; H, HSV-1; TMD, transmembrane domain; CD, cytoplasmic domain; ECD, ectodomain; F, forward; R, reverse. Nucleotide positions in the PrV Ka genome refer to GenBank accession no. JQ809328 and for HSV-1 strain F to GenBank accession no. GU734771.
Nonmatching nucleotides are printed in boldface, and restriction sites for convenient cloning of PCR products are underlined. HSV-1 and PrV gD sequences are shown in italics.
Reverse-strand PCR primers are indicated (r).